← HUTCHMED (China) Ltd
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $11.7m | ($26.7m) | ($74.8m) | ($106.0m) | ($125.7m) | ($194.6m) | ($360.8m) | $100.8m | $37.7m | $456.9m | |
| Net Income (Loss) Available to Common Stockholders, Basic | $11.7m | ($26.7m) | — | — | — | — | — | — | — | — | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $14.6m | ($23.0m) | ($71.3m) | ($103.7m) | ($115.5m) | ($167.0m) | ($360.4m) | $101.1m | $38.2m | $457.7m | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $11.7m | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $14.6m | — | — | — | — | — | — | — | — | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $2.9m | $3.8m | $3.5m | $2.3m | $10.2m | $27.6m | $449k | $314k | $441k | $823k | |
| Depreciation, Depletion and Amortization | $2.3m | $2.6m | $3.6m | $4.9m | $6.1m | $7.2m | $8.7m | $8.2m | $12.3m | $13.3m | |
| Depreciation | $2.2m | $2.5m | $3.5m | $4.8m | $5.9m | $6.8m | $8.3m | $7.9m | $12.1m | $12.0m | |
| Amortization | $35k | — | — | — | — | — | — | — | — | — | |
| Amortization of Debt Issuance Costs | $92k | $147k | $76k | $195k | $43k | $44k | $18k | — | — | — | |
| Deferred Income Tax Expense (Benefit) | — | $1.7m | $2.0m | $1.6m | $3.3m | ($4.7m) | ($3.6m) | $2.2m | $5.3m | ($118k) | |
| Equity Method Investment, Other than Temporary Impairment | — | — | — | — | — | — | $130k | — | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | — | — | — | — | — | — | — | — | |
| Operating Lease, Impairment Loss | — | — | — | — | — | — | — | $2.1m | $1.9m | — | |
| Equity Method Investment, Realized Gain (Loss) on Disposal | — | — | — | — | — | — | — | — | — | $476.9m | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($30k) | ($57k) | ($33k) | ($17k) | ($85k) | ($70k) | ($111k) | ($86k) | ($10k) | $21k | |
| Income (Loss) from Equity Method Investments | $66.2m | $33.7m | $19.3m | $40.7m | $79.0m | $60.6m | $49.8m | $47.3m | $46.5m | $22.7m | |
| Income Tax Expense (Benefit) | $4.3m | $3.1m | $4.0m | $3.3m | $4.8m | $11.9m | ($283k) | $4.5m | $7.2m | $63.6m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $2.9m | $2.9m | |
| Operating Lease, Expense | — | — | — | $4.0m | $3.7m | $4.4m | $5.4m | — | — | — | |
| Other Nonoperating Income (Expense) | ($139k) | — | — | — | — | — | — | — | — | — | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $7.3m | ($2.2m) | $1.6m | $1.2m | $5.3m | $35.6m | $14.5m | $21.3m | $38.5m | ($28.9m) | |
| Increase (Decrease) in Inventories | $3.4m | ($1.0m) | $557k | $4.2m | $3.6m | $16.0m | $21.2m | ($4.1m) | $772k | ($9.5m) | |
| Increase (Decrease) in Accounts Payable | $9.8m | ($11.2m) | $1.3m | ($1.7m) | $7.7m | $9.6m | $29.9m | ($32.5m) | $6.2m | $3.0m | |
| General and Administrative Expense | $21.6m | $24.0m | $30.9m | $39.2m | $50.0m | $89.3m | $92.2m | $79.8m | $64.3m | $66.7m | |
| Goodwill | $3.1m | $3.3m | $3.2m | $3.1m | $3.3m | $3.4m | $3.1m | $3.1m | $3.0m | $3.1m | |
| Investment Income, Interest | $502k | $1.2m | $6.0m | $4.9m | $3.2m | $2.1m | $9.6m | $36.1m | $40.1m | $49.9m | |
| Nonoperating Income (Expense) | ($659k) | ($119k) | $6.0m | $5.3m | $6.9m | ($8.7m) | ($2.7m) | $39.9m | $42.6m | $61.0m | |
| Operating Expenses | $262.8m | — | — | — | — | — | — | — | — | — | |
| Stock or Unit Option Plan Expense | $1.8m | $1.3m | $7.9m | $7.2m | $8.7m | $16.4m | $6.7m | $6.2m | $3.1m | $2.5m | |
| Net Cash Provided by (Used in) Operating Activities | ($9.6m) | ($8.9m) | ($32.8m) | ($80.9m) | ($62.1m) | ($204.2m) | ($268.6m) | $219.3m | $497k | ($64.7m) | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $4.3m | $5.0m | $6.4m | $8.6m | $7.9m | $16.4m | $36.7m | $32.6m | $17.9m | $14.1m | |
| Net Cash Provided by (Used in) Investing Activities | ($33.6m) | ($260.8m) | $43.8m | $119.0m | ($125.4m) | ($306.3m) | $296.6m | ($291.1m) | ($96.1m) | ($29.4m) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Common Stock | $110.6m | $301.7m | $3.9m | $251k | $318.9m | $717.3m | $174k | $5.1m | $790k | $1.6m | |
| Payments for Repurchase of Common Stock | $604k | $1.4m | $5.5m | $346k | $12.9m | $27.3m | $48.1m | $9.1m | $36.1m | — | |
| Net Cash Provided by (Used in) Financing Activities | $92.4m | $273.2m | ($8.2m) | ($1.5m) | $296.4m | $650.0m | ($82.8m) | $48.7m | ($30.7m) | $7.8m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $771k | $35.1m | $114.5m | $141.9m | ($64.3m) | ($29.7m) | ($129.6m) | ($82.6m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $86.0m | $121.2m | $235.6m | $377.5m | $313.3m | $283.6m | $154.0m | $71.3m | |
| Cash, Cash Equivalents, and Short-term Investments | — | — | — | — | — | $1.0b | $631.0m | $886.3m | $836.1m | $1.4b | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $763k | $979k | $917k | $815k | $425k | $150k | $421k | $2.5m | $2.5m | |
| Income Taxes Paid, Net | ($2.7m) | $3.8m | $3.8m | $3.2m | $5.9m | $5.0m | $18.9m | $3.7m | $3.6m | $62.4m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.